相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Sphingosine-1-Phosphate Enhances α1-Adrenergic Vasoconstriction via S1P2-G12/13-ROCK Mediated Signaling
Cecilia R. Panta et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Selective coupling of the S1P3 receptor subtype to S1P-mediated RhoA activation and cardioprotection
Bryan S. Yung et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2017)
HDL-associated ApoM is anti-apoptotic by delivering sphingosine 1-phosphate to S1P1 & S1P3 receptors on vascular endothelium
Mario Ruiz et al.
LIPIDS IN HEALTH AND DISEASE (2017)
Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway: Therapeutic Targets in Autoimmunity and Inflammation
Hsing-Chuan Tsai et al.
DRUGS (2016)
HDL-bound sphingosine-1-phosphate restrains lymphopoiesis and neuroinflammation
Victoria A. Blaho et al.
NATURE (2015)
Acute Coronary Syndrome
Nader Makki et al.
JOURNAL OF INTENSIVE CARE MEDICINE (2015)
The role of sphingosine-1-phosphate in endothelial barrier function
Brent A. Wilkerson et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2014)
The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective
Syed S. Mahmood et al.
LANCET (2014)
Review: Novel insights into the regulation of vascular tone by sphingosine 1-phosphate
D. Kerage et al.
PLACENTA (2014)
Sphingosine kinase and sphingosine 1-phosphate in the heart: A decade of progress
Joel S. Karliner
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2013)
Sphingosine 1-phosphate release from platelets during clot formation: close correlation between platelet count and serum sphingosine 1-phosphate concentration
Yoshikazu Ono et al.
LIPIDS IN HEALTH AND DISEASE (2013)
PLCε, PKD1, and SSH1L Transduce RhoA Signaling to Protect Mitochondria from Oxidative Stress in the Heart
Sunny Y. Xiang et al.
SCIENCE SIGNALING (2013)
Early cardiac dysfunction is rescued by upregulation of SERCA2a pump activity in a rat model of metabolic syndrome
Z. Miklos et al.
ACTA PHYSIOLOGICA (2012)
Insights into the pharmacological relevance of lysophospholipid receptors
Tetsuji Mutoh et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Release of sphingosine-1-phosphate from human platelets is dependent on thromboxane formation
T. Ulrych et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Hearts of surviving MLP-KO mice show transient changes of intracellular calcium handling
Peter Kemecsei et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2010)
Sphingosine 1-Phosphate (S1P) Regulates Vascular Contraction via S1P3 Receptor: Investigation Based on a New S1P3 Receptor Antagonist
Akira Murakami et al.
MOLECULAR PHARMACOLOGY (2010)
Sphingosine-1-phosphate and modulation of vascular tone
Junsuke Igarashi et al.
CARDIOVASCULAR RESEARCH (2009)
Sphingosine Kinase and Sphingosine 1-Phosphate in Cardioprotection
Joel S. Karliner
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2009)
Mechanisms of the negative inotropic effects of sphingosine-1-phosphate on adult mouse ventricular myocytes
Lee K. Landeen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Vascular endothelium as a contributor of plasma sphingosine 1-phosphate
Krishnan Venkataraman et al.
CIRCULATION RESEARCH (2008)
S1P1 receptor localization confers selectivity for Gi-mediated cAMP and contractile responses
Christopher Kable Means et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury
Christopher K. Means et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Sphingosine-1-phosphate signaling in the cardiovascular system
Stephan L. M. Peters et al.
CURRENT OPINION IN PHARMACOLOGY (2007)
High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor
Gregor Theilmeier et al.
CIRCULATION (2006)
Sphingosine-1-phosphate acts via Rho-associated kinase and nitric oxide to regulate human placental vascular tone
DG Hemmings et al.
BIOLOGY OF REPRODUCTION (2006)
Mechanisms of sphingosine and sphingosine 1-phosphate generation in human platelets
M Tani et al.
JOURNAL OF LIPID RESEARCH (2005)
Effects of exogenous sphinganine, sphingosine, and sphingosine-1-phosphate on relaxation and contraction of porcine thoracic aortic and pulmonary arterial rings
SH Hsiao et al.
TOXICOLOGICAL SCIENCES (2005)
Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes
M Forrest et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate
MG Sanna et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3
JR Nofer et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Sphingosine 1-phosphate-induced vasoconstriction is elevated in mesenteric resistance arteries from aged female rats
DG Hemmings et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Sphingosine I-phosphate enhances portal pressure in isolated perfused liver via S1P2 with Rho activation
H Ikeda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
The sphingosine-1-phosphate receptors S1P1, S1P2, and S1P3 function coordinately during embryonic angiogenesis
M Kono et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
High-density lipoprotein stimulates myocardial perfusion in vivo
B Levkau et al.
CIRCULATION (2004)
Heterologous desensitization of the sphingosine-1-phosphate receptors by purinoceptor activation in renal mesangial cells
CY Xin et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G protein-coupled receptors
MH Graler et al.
FASEB JOURNAL (2004)
Sphingosine kinase activation mediates ischemic preconditioning in murine heart
ZQ Jin et al.
CIRCULATION (2004)
Prostacyclin-mediated compensatory mechanism in the coronary circulation during acute NO synthase blockade
Z Lacza et al.
LIFE SCIENCES (2003)
Predicting obstructive coronary artery disease with serum sphingosine-1-phosphate
DH Deutschman et al.
AMERICAN HEART JOURNAL (2003)
S1P3 receptors mediate the potent constriction of cerebral arteries by sphingosine-1-phosphate
S Salomone et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
Sphingosine 1-phosphate induces contraction of coronary artery smooth muscle cells via SS1P2
T Ohmori et al.
CARDIOVASCULAR RESEARCH (2003)
Plasma lipoproteins behave as carriers of extracellular sphingosine 1-phosphate: is this an atherogenic mediator or an anti-atherogenic mediator?
F Okajima
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2002)
Athero- and thrombogenic actions of lysophosphatidic acid and sphingosine-l-phosphate
W Siess
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2002)
Sphingosine 1-phosphate contracts canine basilar arteries in vitro and in vivo - Possible role in pathogenesis of cerebral vasospasm
M Tosaka et al.
STROKE (2001)
The lysophospholipids sphingosine-1-phosphate and lysophosphatidic acid enhance survival during hypoxia in neonatal rat cardiac myocytes
JS Karliner et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2001)
Sphingosine 1-phosphate activates Akt, nitric oxide production, and chemotaxis through a Gi protein/phosphoinositide 3-kinase pathway in endothelial cells
M Morales-Ruiz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Sphingosine 1-phosphate induces sinus tachycardia and coronary vasoconstriction in the canine heart
A Sugiyama et al.
CARDIOVASCULAR RESEARCH (2000)
分享论文
